SHINE Technologies has partnered with Antelope Surgical Solutions, a biotech company pioneering next-generation multimodal radiopharmaceuticals, the company announced recently. According to a release, the supply agreement will accelerate Antelope’s clinical…
SHINE Technologies is partnering with Primo Biotechnology, a developer of high-precision radiopharmaceuticals, the company announced today. According to a release, the agreement grants Primo exclusive distribution rights for SHINE’s Ilumira…
SHINE Technologies and WARF Therapeutics today announced pre-clinical research results from collaborative efforts with the Advanced Radiotheranostics Lab at the University of Wisconsin. According to a release, the studies showed…
SHINE Technologies was awarded another Department of Energy’s Small Business Innovation Research Grant to help transform DOE-supported science and technology breakthroughs into viable products and services, creating a bridge between…
SHINE Technologies announced recently that it is entering into a supply agreement with GlyTherix Ltd, an Australian targeted-radiotherapy company specializing in developing antibody radiopharmaceuticals for solid tumors. According to a…
SHINE Technologies was awarded $32 million from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the organization announced today. According to a release, the funds will aid in the…
SHINE Technologies has partnered with Zeno Power, a developer of commercial Radioisotope Power Systems (RPSs), the company recently announced. According to a release, SHINE plans to provide Zeno with Strontium-90…
SHINE Technologies announced recently that it has partnered with Blue Earth Therapeutics, a company focused on developing innovative radiopharmaceuticals. According to a release, SHINE has provided to Blue Earth Therapeutics…
SHINE Technologies has signed a Memorandum of Understanding (MOU) with Orano to cooperate in the development of the U.S. pilot plant with commercial-scale technology for recycling used nuclear fuel from…
SHINE Technologies and Nucleus RadioPharma are partnering to advance radioligand cancer treatments, SHINE announced recently. “We are proud to partner with Nucleus RadioPharma to supply the high-purity lutetium-177 that powers…
